nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—FGFR1—cleft lip	0.337	0.5	CbGaD
Sunitinib—FGFR2—cleft lip	0.337	0.5	CbGaD
Sunitinib—MYLK3—tongue—cleft lip	0.00319	0.0309	CbGeAlD
Sunitinib—MYLK3—mouth—cleft lip	0.00215	0.0208	CbGeAlD
Sunitinib—FGFR2—skull—cleft lip	0.00198	0.0192	CbGeAlD
Sunitinib—CSF1R—periosteum—cleft lip	0.00184	0.0179	CbGeAlD
Sunitinib—PHKG1—mouth—cleft lip	0.00143	0.0138	CbGeAlD
Sunitinib—STK38—mouth—cleft lip	0.00124	0.012	CbGeAlD
Sunitinib—ULK3—tongue—cleft lip	0.00115	0.0112	CbGeAlD
Sunitinib—NIM1K—telencephalon—cleft lip	0.00109	0.0106	CbGeAlD
Sunitinib—GRK1—telencephalon—cleft lip	0.00109	0.0106	CbGeAlD
Sunitinib—DYRK2—head—cleft lip	0.00106	0.0102	CbGeAlD
Sunitinib—PIP4K2B—telencephalon—cleft lip	0.00105	0.0101	CbGeAlD
Sunitinib—GRK7—head—cleft lip	0.00094	0.00911	CbGeAlD
Sunitinib—STK17A—telencephalon—cleft lip	0.000928	0.009	CbGeAlD
Sunitinib—CDK14—telencephalon—cleft lip	0.000915	0.00887	CbGeAlD
Sunitinib—CDK16—telencephalon—cleft lip	0.000902	0.00874	CbGeAlD
Sunitinib—PAK3—telencephalon—cleft lip	0.000902	0.00874	CbGeAlD
Sunitinib—OXSR1—embryo—cleft lip	0.000899	0.00872	CbGeAlD
Sunitinib—RPS6KA5—telencephalon—cleft lip	0.00089	0.00862	CbGeAlD
Sunitinib—RPS6KA2—embryo—cleft lip	0.000885	0.00858	CbGeAlD
Sunitinib—CLK4—telencephalon—cleft lip	0.000857	0.0083	CbGeAlD
Sunitinib—DAPK1—telencephalon—cleft lip	0.000828	0.00802	CbGeAlD
Sunitinib—MYLK—embryo—cleft lip	0.000813	0.00788	CbGeAlD
Sunitinib—BRD4—telencephalon—cleft lip	0.000801	0.00777	CbGeAlD
Sunitinib—TLK2—head—cleft lip	0.0008	0.00775	CbGeAlD
Sunitinib—TNIK—telencephalon—cleft lip	0.000778	0.00754	CbGeAlD
Sunitinib—ULK3—mouth—cleft lip	0.000776	0.00752	CbGeAlD
Sunitinib—MYLK3—head—cleft lip	0.000774	0.0075	CbGeAlD
Sunitinib—ICK—telencephalon—cleft lip	0.000764	0.0074	CbGeAlD
Sunitinib—ALK—embryo—cleft lip	0.000755	0.00731	CbGeAlD
Sunitinib—NUAK1—telencephalon—cleft lip	0.000738	0.00715	CbGeAlD
Sunitinib—INSR—telencephalon—cleft lip	0.000731	0.00709	CbGeAlD
Sunitinib—SNRK—telencephalon—cleft lip	0.000731	0.00709	CbGeAlD
Sunitinib—OXSR1—telencephalon—cleft lip	0.000731	0.00709	CbGeAlD
Sunitinib—STK38—telencephalon—cleft lip	0.00072	0.00698	CbGeAlD
Sunitinib—RPS6KA2—telencephalon—cleft lip	0.00072	0.00698	CbGeAlD
Sunitinib—CSNK1G2—telencephalon—cleft lip	0.000709	0.00687	CbGeAlD
Sunitinib—PKN1—telencephalon—cleft lip	0.000709	0.00687	CbGeAlD
Sunitinib—PRPF4—telencephalon—cleft lip	0.000698	0.00677	CbGeAlD
Sunitinib—ROCK1—embryo—cleft lip	0.000696	0.00674	CbGeAlD
Sunitinib—PRPF4B—telencephalon—cleft lip	0.000689	0.00667	CbGeAlD
Sunitinib—FGFR2—mouth—cleft lip	0.000686	0.00664	CbGeAlD
Sunitinib—GRK1—head—cleft lip	0.00068	0.00659	CbGeAlD
Sunitinib—NIM1K—head—cleft lip	0.00068	0.00659	CbGeAlD
Sunitinib—STK39—telencephalon—cleft lip	0.000679	0.00658	CbGeAlD
Sunitinib—CSNK2A1—telencephalon—cleft lip	0.00067	0.00649	CbGeAlD
Sunitinib—MYLK—telencephalon—cleft lip	0.000662	0.00641	CbGeAlD
Sunitinib—PIP4K2B—head—cleft lip	0.000652	0.00632	CbGeAlD
Sunitinib—ERN1—head—cleft lip	0.000652	0.00632	CbGeAlD
Sunitinib—MAST1—head—cleft lip	0.000639	0.00619	CbGeAlD
Sunitinib—STK24—telencephalon—cleft lip	0.000634	0.00615	CbGeAlD
Sunitinib—RPS6KA3—embryo—cleft lip	0.000633	0.00613	CbGeAlD
Sunitinib—MAP2K1—embryo—cleft lip	0.000629	0.00609	CbGeAlD
Sunitinib—DAPK2—telencephalon—cleft lip	0.000627	0.00608	CbGeAlD
Sunitinib—HIPK2—telencephalon—cleft lip	0.000614	0.00595	CbGeAlD
Sunitinib—TYRO3—telencephalon—cleft lip	0.000614	0.00595	CbGeAlD
Sunitinib—DCLK3—head—cleft lip	0.000606	0.00587	CbGeAlD
Sunitinib—DAPK3—telencephalon—cleft lip	0.00059	0.00571	CbGeAlD
Sunitinib—PTK2B—embryo—cleft lip	0.000584	0.00566	CbGeAlD
Sunitinib—FLT4—embryo—cleft lip	0.000583	0.00565	CbGeAlD
Sunitinib—ROCK1—telencephalon—cleft lip	0.000566	0.00549	CbGeAlD
Sunitinib—PAK3—head—cleft lip	0.000562	0.00544	CbGeAlD
Sunitinib—CDK16—head—cleft lip	0.000562	0.00544	CbGeAlD
Sunitinib—RPS6KA5—head—cleft lip	0.000554	0.00537	CbGeAlD
Sunitinib—DYRK1A—telencephalon—cleft lip	0.000552	0.00535	CbGeAlD
Sunitinib—MERTK—telencephalon—cleft lip	0.000539	0.00523	CbGeAlD
Sunitinib—CLK4—head—cleft lip	0.000534	0.00517	CbGeAlD
Sunitinib—MAP4K4—telencephalon—cleft lip	0.000529	0.00513	CbGeAlD
Sunitinib—SBK1—head—cleft lip	0.000527	0.00511	CbGeAlD
Sunitinib—MAP3K12—telencephalon—cleft lip	0.000522	0.00506	CbGeAlD
Sunitinib—RPS6KB1—embryo—cleft lip	0.000518	0.00502	CbGeAlD
Sunitinib—DAPK1—head—cleft lip	0.000515	0.00499	CbGeAlD
Sunitinib—PHKG1—head—cleft lip	0.000515	0.00499	CbGeAlD
Sunitinib—RPS6KA3—telencephalon—cleft lip	0.000515	0.00499	CbGeAlD
Sunitinib—FGR—embryo—cleft lip	0.000515	0.00499	CbGeAlD
Sunitinib—RET—embryo—cleft lip	0.000515	0.00499	CbGeAlD
Sunitinib—MAP2K1—telencephalon—cleft lip	0.000511	0.00495	CbGeAlD
Sunitinib—CSNK1A1—telencephalon—cleft lip	0.000505	0.00489	CbGeAlD
Sunitinib—CLK1—telencephalon—cleft lip	0.000501	0.00486	CbGeAlD
Sunitinib—STK11—head—cleft lip	0.000499	0.00484	CbGeAlD
Sunitinib—BRD4—head—cleft lip	0.000499	0.00484	CbGeAlD
Sunitinib—RIOK1—head—cleft lip	0.000494	0.00479	CbGeAlD
Sunitinib—CAMK2G—telencephalon—cleft lip	0.000492	0.00477	CbGeAlD
Sunitinib—FGFR2—embryo—cleft lip	0.000489	0.00474	CbGeAlD
Sunitinib—LRRK2—telencephalon—cleft lip	0.000488	0.00473	CbGeAlD
Sunitinib—JAK2—embryo—cleft lip	0.000486	0.00471	CbGeAlD
Sunitinib—MARK2—head—cleft lip	0.000484	0.00469	CbGeAlD
Sunitinib—SGK3—head—cleft lip	0.00048	0.00465	CbGeAlD
Sunitinib—FYN—embryo—cleft lip	0.00048	0.00465	CbGeAlD
Sunitinib—KIT—mouth—cleft lip	0.000476	0.00461	CbGeAlD
Sunitinib—ICK—head—cleft lip	0.000476	0.00461	CbGeAlD
Sunitinib—PTK2B—telencephalon—cleft lip	0.000475	0.00461	CbGeAlD
Sunitinib—FGFR1—telencephalon—cleft lip	0.000468	0.00453	CbGeAlD
Sunitinib—CSNK1E—telencephalon—cleft lip	0.000468	0.00453	CbGeAlD
Sunitinib—NUAK1—head—cleft lip	0.000459	0.00445	CbGeAlD
Sunitinib—SNRK—head—cleft lip	0.000456	0.00441	CbGeAlD
Sunitinib—INSR—head—cleft lip	0.000456	0.00441	CbGeAlD
Sunitinib—FLT1—embryo—cleft lip	0.000453	0.00439	CbGeAlD
Sunitinib—ULK3—telencephalon—cleft lip	0.00045	0.00436	CbGeAlD
Sunitinib—MAP2K2—telencephalon—cleft lip	0.00045	0.00436	CbGeAlD
Sunitinib—STK38—head—cleft lip	0.000448	0.00434	CbGeAlD
Sunitinib—RPS6KA2—head—cleft lip	0.000448	0.00434	CbGeAlD
Sunitinib—MAP3K2—telencephalon—cleft lip	0.000447	0.00433	CbGeAlD
Sunitinib—AURKC—head—cleft lip	0.000445	0.00431	CbGeAlD
Sunitinib—MAP3K7—telencephalon—cleft lip	0.000443	0.00429	CbGeAlD
Sunitinib—CSNK1G2—head—cleft lip	0.000441	0.00428	CbGeAlD
Sunitinib—PKN1—head—cleft lip	0.000441	0.00428	CbGeAlD
Sunitinib—TBK1—telencephalon—cleft lip	0.000438	0.00424	CbGeAlD
Sunitinib—PRPF4—head—cleft lip	0.000435	0.00421	CbGeAlD
Sunitinib—TYK2—telencephalon—cleft lip	0.000435	0.00421	CbGeAlD
Sunitinib—IRAK1—telencephalon—cleft lip	0.000429	0.00416	CbGeAlD
Sunitinib—PRPF4B—head—cleft lip	0.000429	0.00415	CbGeAlD
Sunitinib—PDGFRA—embryo—cleft lip	0.000425	0.00411	CbGeAlD
Sunitinib—STK39—head—cleft lip	0.000423	0.0041	CbGeAlD
Sunitinib—RPS6KB1—telencephalon—cleft lip	0.000421	0.00408	CbGeAlD
Sunitinib—CSNK2A1—head—cleft lip	0.000417	0.00404	CbGeAlD
Sunitinib—AXL—telencephalon—cleft lip	0.000417	0.00404	CbGeAlD
Sunitinib—MYLK—head—cleft lip	0.000412	0.00399	CbGeAlD
Sunitinib—STK4—head—cleft lip	0.000404	0.00392	CbGeAlD
Sunitinib—SLK—telencephalon—cleft lip	0.000401	0.00389	CbGeAlD
Sunitinib—FGFR2—telencephalon—cleft lip	0.000398	0.00385	CbGeAlD
Sunitinib—PHKG2—head—cleft lip	0.000397	0.00385	CbGeAlD
Sunitinib—JAK2—telencephalon—cleft lip	0.000395	0.00383	CbGeAlD
Sunitinib—STK24—head—cleft lip	0.000395	0.00383	CbGeAlD
Sunitinib—FYN—telencephalon—cleft lip	0.00039	0.00378	CbGeAlD
Sunitinib—STK16—head—cleft lip	0.000384	0.00372	CbGeAlD
Sunitinib—KDR—embryo—cleft lip	0.000383	0.00371	CbGeAlD
Sunitinib—HIPK2—head—cleft lip	0.000382	0.0037	CbGeAlD
Sunitinib—ALK—head—cleft lip	0.000382	0.0037	CbGeAlD
Sunitinib—TYRO3—head—cleft lip	0.000382	0.0037	CbGeAlD
Sunitinib—MAP4K5—telencephalon—cleft lip	0.000381	0.00369	CbGeAlD
Sunitinib—RIOK2—head—cleft lip	0.000378	0.00366	CbGeAlD
Sunitinib—MAP3K19—head—cleft lip	0.000374	0.00363	CbGeAlD
Sunitinib—CSF1R—embryo—cleft lip	0.000374	0.00362	CbGeAlD
Sunitinib—FLT1—telencephalon—cleft lip	0.000369	0.00357	CbGeAlD
Sunitinib—DAPK3—head—cleft lip	0.000367	0.00356	CbGeAlD
Sunitinib—EPHB6—telencephalon—cleft lip	0.000364	0.00353	CbGeAlD
Sunitinib—CLK2—head—cleft lip	0.000364	0.00352	CbGeAlD
Sunitinib—STK3—head—cleft lip	0.000357	0.00346	CbGeAlD
Sunitinib—ROCK1—head—cleft lip	0.000353	0.00342	CbGeAlD
Sunitinib—YES1—telencephalon—cleft lip	0.000352	0.00341	CbGeAlD
Sunitinib—TAOK3—telencephalon—cleft lip	0.000348	0.00337	CbGeAlD
Sunitinib—PDGFRA—telencephalon—cleft lip	0.000345	0.00335	CbGeAlD
Sunitinib—DYRK1A—head—cleft lip	0.000344	0.00333	CbGeAlD
Sunitinib—KIT—embryo—cleft lip	0.000339	0.00329	CbGeAlD
Sunitinib—MERTK—head—cleft lip	0.000336	0.00325	CbGeAlD
Sunitinib—PDGFRB—embryo—cleft lip	0.000332	0.00321	CbGeAlD
Sunitinib—MAP4K4—head—cleft lip	0.00033	0.00319	CbGeAlD
Sunitinib—MAP3K12—head—cleft lip	0.000325	0.00315	CbGeAlD
Sunitinib—RPS6KA3—head—cleft lip	0.00032	0.00311	CbGeAlD
Sunitinib—MAP2K1—head—cleft lip	0.000318	0.00308	CbGeAlD
Sunitinib—CSNK1A1—head—cleft lip	0.000314	0.00304	CbGeAlD
Sunitinib—CLK1—head—cleft lip	0.000312	0.00302	CbGeAlD
Sunitinib—MAP2K5—telencephalon—cleft lip	0.000312	0.00302	CbGeAlD
Sunitinib—BMP2K—head—cleft lip	0.000306	0.00297	CbGeAlD
Sunitinib—CAMK2G—head—cleft lip	0.000306	0.00297	CbGeAlD
Sunitinib—CSF1R—telencephalon—cleft lip	0.000304	0.00295	CbGeAlD
Sunitinib—LRRK2—head—cleft lip	0.000304	0.00294	CbGeAlD
Sunitinib—PRKAA1—head—cleft lip	0.000299	0.0029	CbGeAlD
Sunitinib—PTK2B—head—cleft lip	0.000296	0.00287	CbGeAlD
Sunitinib—FLT4—head—cleft lip	0.000295	0.00286	CbGeAlD
Sunitinib—CSNK1E—head—cleft lip	0.000291	0.00282	CbGeAlD
Sunitinib—IRAK4—head—cleft lip	0.000287	0.00278	CbGeAlD
Sunitinib—MAP2K2—head—cleft lip	0.00028	0.00272	CbGeAlD
Sunitinib—ULK3—head—cleft lip	0.00028	0.00272	CbGeAlD
Sunitinib—MAP3K2—head—cleft lip	0.000278	0.0027	CbGeAlD
Sunitinib—KIT—telencephalon—cleft lip	0.000276	0.00267	CbGeAlD
Sunitinib—TBK1—head—cleft lip	0.000273	0.00264	CbGeAlD
Sunitinib—TYK2—head—cleft lip	0.000271	0.00262	CbGeAlD
Sunitinib—PDGFRB—telencephalon—cleft lip	0.00027	0.00261	CbGeAlD
Sunitinib—RPS6KB1—head—cleft lip	0.000262	0.00254	CbGeAlD
Sunitinib—FGR—head—cleft lip	0.000261	0.00252	CbGeAlD
Sunitinib—RET—head—cleft lip	0.000261	0.00252	CbGeAlD
Sunitinib—AXL—head—cleft lip	0.00026	0.00251	CbGeAlD
Sunitinib—FGFR2—head—cleft lip	0.000248	0.0024	CbGeAlD
Sunitinib—JAK2—head—cleft lip	0.000246	0.00239	CbGeAlD
Sunitinib—FYN—head—cleft lip	0.000243	0.00235	CbGeAlD
Sunitinib—MAP3K3—head—cleft lip	0.000237	0.0023	CbGeAlD
Sunitinib—MAP4K5—head—cleft lip	0.000237	0.0023	CbGeAlD
Sunitinib—FLT1—head—cleft lip	0.000229	0.00222	CbGeAlD
Sunitinib—EPHB6—head—cleft lip	0.000227	0.0022	CbGeAlD
Sunitinib—YES1—head—cleft lip	0.000219	0.00212	CbGeAlD
Sunitinib—STK10—head—cleft lip	0.000217	0.0021	CbGeAlD
Sunitinib—TAOK3—head—cleft lip	0.000216	0.0021	CbGeAlD
Sunitinib—PDGFRA—head—cleft lip	0.000215	0.00208	CbGeAlD
Sunitinib—KDR—head—cleft lip	0.000194	0.00188	CbGeAlD
Sunitinib—MAP2K5—head—cleft lip	0.000194	0.00188	CbGeAlD
Sunitinib—CSF1R—head—cleft lip	0.000189	0.00183	CbGeAlD
Sunitinib—KIT—head—cleft lip	0.000172	0.00167	CbGeAlD
Sunitinib—KCNH2—telencephalon—cleft lip	0.00017	0.00165	CbGeAlD
Sunitinib—PDGFRB—head—cleft lip	0.000168	0.00163	CbGeAlD
Sunitinib—ABCG2—telencephalon—cleft lip	0.000152	0.00147	CbGeAlD
Sunitinib—ABCC4—head—cleft lip	0.000134	0.0013	CbGeAlD
Sunitinib—KCNH2—head—cleft lip	0.000106	0.00103	CbGeAlD
Sunitinib—ABCB1—embryo—cleft lip	9.19e-05	0.00089	CbGeAlD
Sunitinib—ABCB1—telencephalon—cleft lip	7.47e-05	0.000724	CbGeAlD
Sunitinib—ABCB1—head—cleft lip	4.65e-05	0.000451	CbGeAlD
Sunitinib—MAP2K2—Signaling Pathways—FGF9—cleft lip	3.98e-06	1.78e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—FGFR3—cleft lip	3.98e-06	1.78e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—FGFR2—cleft lip	3.98e-06	1.78e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGF10—cleft lip	3.96e-06	1.77e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—FGFR3—cleft lip	3.95e-06	1.77e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—FGFR1—cleft lip	3.95e-06	1.77e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—FGFR1—cleft lip	3.92e-06	1.75e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—FGFR2—cleft lip	3.92e-06	1.75e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FGF10—cleft lip	3.91e-06	1.75e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—FGFR2—cleft lip	3.9e-06	1.74e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—MYC—cleft lip	3.9e-06	1.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—FGFR1—cleft lip	3.89e-06	1.74e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGF9—cleft lip	3.89e-06	1.74e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—FGFR1—cleft lip	3.89e-06	1.74e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—FGFR3—cleft lip	3.88e-06	1.74e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—FGFR3—cleft lip	3.88e-06	1.73e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—FGFR2—cleft lip	3.85e-06	1.72e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGF10—cleft lip	3.84e-06	1.72e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGF10—cleft lip	3.84e-06	1.72e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGF3—cleft lip	3.84e-06	1.72e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGF3—cleft lip	3.82e-06	1.71e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—FGFR1—cleft lip	3.81e-06	1.7e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—FGFR1—cleft lip	3.81e-06	1.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—FGFR1—cleft lip	3.79e-06	1.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—FGFR2—cleft lip	3.76e-06	1.68e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—MYC—cleft lip	3.75e-06	1.68e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGF9—cleft lip	3.75e-06	1.68e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—FGFR3—cleft lip	3.73e-06	1.67e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FGFR2—cleft lip	3.73e-06	1.67e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGF9—cleft lip	3.73e-06	1.67e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—FGFR3—cleft lip	3.71e-06	1.66e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—FGFR1—cleft lip	3.71e-06	1.66e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MTHFR—cleft lip	3.71e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—FGFR3—cleft lip	3.68e-06	1.65e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—FGFR3—cleft lip	3.67e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—FGFR3—cleft lip	3.67e-06	1.64e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—FGFR1—cleft lip	3.66e-06	1.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGF3—cleft lip	3.65e-06	1.63e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGF10—cleft lip	3.65e-06	1.63e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGF10—cleft lip	3.64e-06	1.63e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—FGF2—cleft lip	3.64e-06	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—FGFR1—cleft lip	3.64e-06	1.63e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—FGFR2—cleft lip	3.62e-06	1.62e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MTHFR—cleft lip	3.62e-06	1.62e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—FGFR2—cleft lip	3.6e-06	1.61e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—FGFR3—cleft lip	3.6e-06	1.61e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—FGFR3—cleft lip	3.6e-06	1.61e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—FGFR1—cleft lip	3.59e-06	1.6e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—FGFR3—cleft lip	3.58e-06	1.6e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—MYC—cleft lip	3.57e-06	1.59e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—MYC—cleft lip	3.57e-06	1.59e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGF9—cleft lip	3.56e-06	1.59e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—FGF2—cleft lip	3.52e-06	1.57e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—FGFR3—cleft lip	3.51e-06	1.57e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—FGFR1—cleft lip	3.5e-06	1.57e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—MTHFR—cleft lip	3.49e-06	1.56e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FGFR1—cleft lip	3.48e-06	1.55e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—NOS3—cleft lip	3.47e-06	1.55e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MTHFR—cleft lip	3.47e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—MYC—cleft lip	3.46e-06	1.55e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—FGFR3—cleft lip	3.46e-06	1.54e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FGFR2—cleft lip	3.45e-06	1.54e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—FGF2—cleft lip	3.45e-06	1.54e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—FGFR2—cleft lip	3.44e-06	1.54e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—FGFR3—cleft lip	3.44e-06	1.54e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TCN2—cleft lip	3.43e-06	1.53e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—FGFR3—cleft lip	3.39e-06	1.52e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—FGFR1—cleft lip	3.38e-06	1.51e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGF10—cleft lip	3.36e-06	1.5e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—FGFR1—cleft lip	3.36e-06	1.5e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—FGF2—cleft lip	3.35e-06	1.5e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—MTHFR—cleft lip	3.31e-06	1.48e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—FGFR3—cleft lip	3.31e-06	1.48e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—FGF2—cleft lip	3.31e-06	1.48e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—FGF2—cleft lip	3.3e-06	1.47e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FGFR3—cleft lip	3.28e-06	1.47e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—MYC—cleft lip	3.28e-06	1.47e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGF10—cleft lip	3.28e-06	1.47e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FGFR2—cleft lip	3.28e-06	1.46e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—FGF2—cleft lip	3.27e-06	1.46e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—NOS3—cleft lip	3.25e-06	1.45e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—FGF2—cleft lip	3.25e-06	1.45e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—FGF2—cleft lip	3.25e-06	1.45e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—NOS3—cleft lip	3.22e-06	1.44e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FGFR1—cleft lip	3.22e-06	1.44e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—FGFR1—cleft lip	3.21e-06	1.43e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MYC—cleft lip	3.19e-06	1.43e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—FGFR3—cleft lip	3.19e-06	1.43e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGFR2—cleft lip	3.18e-06	1.42e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—FGFR3—cleft lip	3.17e-06	1.42e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	3.17e-06	1.41e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGF10—cleft lip	3.16e-06	1.41e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTR—cleft lip	3.15e-06	1.41e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGF10—cleft lip	3.14e-06	1.41e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—FGF2—cleft lip	3.09e-06	1.38e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGFR2—cleft lip	3.09e-06	1.38e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGFR2—cleft lip	3.09e-06	1.38e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—FGF2—cleft lip	3.08e-06	1.38e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—FGF2—cleft lip	3.08e-06	1.37e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FGFR1—cleft lip	3.05e-06	1.37e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—FGF2—cleft lip	3.05e-06	1.37e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—NOS3—cleft lip	3.05e-06	1.36e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FGFR3—cleft lip	3.04e-06	1.36e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—FGFR3—cleft lip	3.03e-06	1.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MYC—cleft lip	3.02e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NOS3—cleft lip	3.01e-06	1.35e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGF10—cleft lip	3e-06	1.34e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—FGF2—cleft lip	3e-06	1.34e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—FGF2—cleft lip	3e-06	1.34e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MYC—cleft lip	2.99e-06	1.33e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGFR1—cleft lip	2.97e-06	1.33e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—NOS3—cleft lip	2.96e-06	1.32e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—NOS3—cleft lip	2.95e-06	1.32e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FGFR1—cleft lip	2.93e-06	1.31e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGFR2—cleft lip	2.93e-06	1.31e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGFR2—cleft lip	2.92e-06	1.31e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FGFR3—cleft lip	2.89e-06	1.29e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—FGF2—cleft lip	2.89e-06	1.29e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGFR1—cleft lip	2.88e-06	1.29e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGFR1—cleft lip	2.88e-06	1.29e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—FGF2—cleft lip	2.87e-06	1.28e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—FGF2—cleft lip	2.85e-06	1.27e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—NOS3—cleft lip	2.85e-06	1.27e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MYC—cleft lip	2.85e-06	1.27e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—FGF2—cleft lip	2.84e-06	1.27e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—FGF2—cleft lip	2.84e-06	1.27e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—NOS3—cleft lip	2.83e-06	1.26e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NOS3—cleft lip	2.81e-06	1.25e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGFR3—cleft lip	2.8e-06	1.25e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NOS3—cleft lip	2.8e-06	1.25e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—FGF2—cleft lip	2.78e-06	1.24e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—FGF2—cleft lip	2.78e-06	1.24e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—FGF2—cleft lip	2.77e-06	1.24e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FGFR3—cleft lip	2.77e-06	1.24e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—NOS3—cleft lip	2.74e-06	1.23e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—NOS3—cleft lip	2.74e-06	1.23e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGFR1—cleft lip	2.72e-06	1.22e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGFR3—cleft lip	2.72e-06	1.22e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGFR3—cleft lip	2.72e-06	1.22e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—FGF2—cleft lip	2.71e-06	1.21e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGFR2—cleft lip	2.7e-06	1.21e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—TYMS—cleft lip	2.7e-06	1.21e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MYC—cleft lip	2.68e-06	1.2e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—TYMS—cleft lip	2.67e-06	1.19e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NOS3—cleft lip	2.67e-06	1.19e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—FGF2—cleft lip	2.67e-06	1.19e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MYC—cleft lip	2.66e-06	1.19e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—FGF2—cleft lip	2.66e-06	1.19e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGFR2—cleft lip	2.63e-06	1.18e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—FGF2—cleft lip	2.62e-06	1.17e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NOS3—cleft lip	2.59e-06	1.16e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGFR3—cleft lip	2.58e-06	1.15e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGFR3—cleft lip	2.57e-06	1.15e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—FGF2—cleft lip	2.56e-06	1.14e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC19A1—cleft lip	2.55e-06	1.14e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FGF2—cleft lip	2.54e-06	1.13e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGFR2—cleft lip	2.54e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGFR2—cleft lip	2.52e-06	1.13e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NOS3—cleft lip	2.52e-06	1.13e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGFR1—cleft lip	2.51e-06	1.12e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—FGF2—cleft lip	2.47e-06	1.1e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGFR1—cleft lip	2.45e-06	1.1e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—FGF2—cleft lip	2.45e-06	1.1e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—NOS3—cleft lip	2.43e-06	1.09e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NOS3—cleft lip	2.42e-06	1.08e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGFR2—cleft lip	2.41e-06	1.08e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTR—cleft lip	2.38e-06	1.06e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGFR3—cleft lip	2.38e-06	1.06e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGFR1—cleft lip	2.36e-06	1.06e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—cleft lip	2.35e-06	1.05e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FGF2—cleft lip	2.35e-06	1.05e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGFR1—cleft lip	2.35e-06	1.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—FGF2—cleft lip	2.34e-06	1.05e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—cleft lip	2.33e-06	1.04e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NOS3—cleft lip	2.32e-06	1.04e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGFR3—cleft lip	2.32e-06	1.04e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—NOS3—cleft lip	2.31e-06	1.03e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MYC—cleft lip	2.3e-06	1.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGFR1—cleft lip	2.25e-06	1e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGFR3—cleft lip	2.23e-06	9.99e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FGF2—cleft lip	2.23e-06	9.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGFR3—cleft lip	2.22e-06	9.93e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NOS3—cleft lip	2.2e-06	9.83e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGF2—cleft lip	2.17e-06	9.68e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MYC—cleft lip	2.16e-06	9.64e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FGF2—cleft lip	2.14e-06	9.56e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MYC—cleft lip	2.14e-06	9.55e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NOS3—cleft lip	2.14e-06	9.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGFR3—cleft lip	2.12e-06	9.49e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TCN2—cleft lip	2.11e-06	9.45e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NOS3—cleft lip	2.11e-06	9.43e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGF2—cleft lip	2.1e-06	9.39e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGF2—cleft lip	2.1e-06	9.39e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NOS3—cleft lip	2.07e-06	9.26e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NOS3—cleft lip	2.07e-06	9.26e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—MYC—cleft lip	2.02e-06	9.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—MYC—cleft lip	2e-06	8.92e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGF2—cleft lip	1.99e-06	8.91e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGF2—cleft lip	1.99e-06	8.89e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NOS3—cleft lip	1.97e-06	8.79e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NOS3—cleft lip	1.96e-06	8.77e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—MYC—cleft lip	1.96e-06	8.77e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MYC—cleft lip	1.96e-06	8.75e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TYMS—cleft lip	1.93e-06	8.63e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MYC—cleft lip	1.89e-06	8.43e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MYC—cleft lip	1.87e-06	8.38e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—MYC—cleft lip	1.86e-06	8.32e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—MYC—cleft lip	1.86e-06	8.3e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGF2—cleft lip	1.84e-06	8.21e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MYC—cleft lip	1.82e-06	8.12e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MYC—cleft lip	1.82e-06	8.12e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—cleft lip	1.81e-06	8.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGF2—cleft lip	1.79e-06	8.01e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MYC—cleft lip	1.77e-06	7.92e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—cleft lip	1.77e-06	7.9e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGF2—cleft lip	1.73e-06	7.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGF2—cleft lip	1.72e-06	7.68e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MYC—cleft lip	1.71e-06	7.66e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—cleft lip	1.7e-06	7.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—cleft lip	1.69e-06	7.57e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—cleft lip	1.69e-06	7.54e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MYC—cleft lip	1.67e-06	7.48e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—cleft lip	1.64e-06	7.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGF2—cleft lip	1.64e-06	7.34e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—cleft lip	1.63e-06	7.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—cleft lip	1.62e-06	7.24e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MYC—cleft lip	1.61e-06	7.21e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MYC—cleft lip	1.6e-06	7.17e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—cleft lip	1.54e-06	6.87e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—cleft lip	1.53e-06	6.85e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTR—cleft lip	1.46e-06	6.55e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—cleft lip	1.46e-06	6.52e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TYMS—cleft lip	1.46e-06	6.52e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—cleft lip	1.42e-06	6.33e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—cleft lip	1.4e-06	6.25e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—cleft lip	1.37e-06	6.14e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—cleft lip	1.37e-06	6.14e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—cleft lip	1.3e-06	5.83e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—cleft lip	1.3e-06	5.81e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—cleft lip	1.27e-06	5.69e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—cleft lip	1.2e-06	5.36e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—cleft lip	1.18e-06	5.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—cleft lip	1.17e-06	5.23e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—cleft lip	1.13e-06	5.05e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—cleft lip	1.12e-06	5.02e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—cleft lip	1.07e-06	4.8e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TYMS—cleft lip	8.98e-07	4.01e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—cleft lip	8.88e-07	3.97e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—cleft lip	7.84e-07	3.51e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—cleft lip	5.47e-07	2.45e-06	CbGpPWpGaD
